These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29089771)
1. A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness. Kopelowicz A; Baker RA; Zhao C; Brewer C; Lawson E; Peters-Strickland T Neuropsychiatr Dis Treat; 2017; 13():2641-2651. PubMed ID: 29089771 [TBL] [Abstract][Full Text] [Related]
2. Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis. Fowler JC; Cope N; Knights J; Phiri P; Makin A; Peters-Strickland T; Rathod S BMJ Open; 2019 Jun; 9(6):e025952. PubMed ID: 31253613 [TBL] [Abstract][Full Text] [Related]
3. Digital Medicine System in Veterans With Severe Mental Illness: Feasibility and Acceptability Study. Gonzales S; Okusaga OO; Reuteman-Fowler JC; Oakes MM; Brown JN; Moore S; Lewinski AA; Rodriguez C; Moncayo N; Smith VA; Malone S; List J; Cho RY; Jeffreys AS; Bosworth HB JMIR Form Res; 2022 Dec; 6(12):e34893. PubMed ID: 36548028 [TBL] [Abstract][Full Text] [Related]
4. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole. Peters-Strickland T; Pestreich L; Hatch A; Rohatagi S; Baker RA; Docherty JP; Markovtsova L; Raja P; Weiden PJ; Walling DP Neuropsychiatr Dis Treat; 2016; 12():2587-2594. PubMed ID: 27785036 [TBL] [Abstract][Full Text] [Related]
5. Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis. Fowler JC; Cope N; Knights J; Fang H; Skubiak T; Shergill SS; Phiri P; Rathod S; Peters-Strickland T Neuropsychiatr Dis Treat; 2021; 17():483-492. PubMed ID: 33603385 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial. Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169 [TBL] [Abstract][Full Text] [Related]
7. Safety Evaluation in Iterative Development of Wearable Patches for Aripiprazole Tablets With Sensor: Pooled Analysis of Clinical Trials. Jan M; Coppin-Renz A; West R; Gallo CL; Cochran JM; Heumen EV; Fahmy M; Reuteman-Fowler JC JMIR Form Res; 2023 Dec; 7():e44768. PubMed ID: 38085556 [TBL] [Abstract][Full Text] [Related]
8. Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study. Flores GP; Peace B; Carnes TC; Baumgartner SL; Buffkin DE; Euliano NR; Smith LN Innov Clin Neurosci; 2016; 13(9-10):12-19. PubMed ID: 27974996 [No Abstract] [Full Text] [Related]
9. Are caregivers ready for digital? Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness. Forma F; Chiu K; Shafrin J; Boskovic DH; Veeranki SP Digit Health; 2022; 8():20552076221084472. PubMed ID: 35295765 [TBL] [Abstract][Full Text] [Related]
10. Optimization of a Digital Medicine System in Psychiatry. Rohatagi S; Profit D; Hatch A; Zhao C; Docherty JP; Peters-Strickland TS J Clin Psychiatry; 2016 Sep; 77(9):e1101-e1107. PubMed ID: 27487251 [TBL] [Abstract][Full Text] [Related]
11. Use of an Ingestible, Sensor-Based Digital Adherence System to Strengthen the Therapeutic Relationship in Serious Mental Illness. Richey AG; Kovacs I; Browne S JMIR Ment Health; 2022 Dec; 9(12):e39047. PubMed ID: 36459392 [TBL] [Abstract][Full Text] [Related]
12. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023 [TBL] [Abstract][Full Text] [Related]
13. Wirelessly Observed Therapy to Optimize Adherence and Target Interventions for Oral Hepatitis C Treatment: Observational Pilot Study. Bonacini M; Kim Y; Pitney C; McKoin L; Tran M; Landis C J Med Internet Res; 2020 Feb; 22(2):e15532. PubMed ID: 32352385 [TBL] [Abstract][Full Text] [Related]
14. Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data. Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS Adv Ther; 2018 Oct; 35(10):1612-1625. PubMed ID: 30206822 [TBL] [Abstract][Full Text] [Related]
15. Human factors evaluation of a novel digital medicine system in psychiatry. Peters-Strickland T; Hatch A; Adenwala A; Atkinson K; Bartfeld B Neuropsychiatr Dis Treat; 2018; 14():553-565. PubMed ID: 29497299 [TBL] [Abstract][Full Text] [Related]
16. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Eisenberger U; Wüthrich RP; Bock A; Ambühl P; Steiger J; Intondi A; Kuranoff S; Maier T; Green D; DiCarlo L; Feutren G; De Geest S Transplantation; 2013 Aug; 96(3):245-50. PubMed ID: 23823651 [TBL] [Abstract][Full Text] [Related]